Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07829497
Recruiting
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Not applicable · United States · 1 site
Registry update: 5 Nov 2026
NCT07746427
Recruiting
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Not applicable · United States · 2 sites
Registry update: 23 Oct 2026
NCT07698535
Recruiting
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Phase 2 · United States · 1 site
Registry update: 19 Oct 2026
NCT07516119
Recruiting
Predicting Pre-dementia
Not applicable · United States · 1 site
Registry update: 22 Sept 2026
NCT07846683
Recruiting
A Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · United States · 1 site
Registry update: 26 Oct 2026
NCT07871071
Recruiting
Brain-Computer Interface Communication Device for People With ALS
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT06863402
Recruiting
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Phase 2 · United States · 1 site
Registry update: 2 Oct 2026
NCT07781657
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Phase 2 · Australia, Belgium, Germany, Denmark, Spain, France, Ireland, Italy, Poland, United States · 47 sites
Registry update: 6 Nov 2026
NCT07908316
Recruiting
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
Phase 1 · United States · 9 sites
Registry update: 2 Nov 2026
NCT07683104
Recruiting
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07619534
Recruiting
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07637669
Recruiting
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT05621291
Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Not applicable · United States · 8 sites
Registry update: 6 Nov 2026
NCT07667400
Recruiting
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Phase 1/2 · United States · 1 site
Registry update: 6 Nov 2026
NCT06406465
Recruiting
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Phase 2 · United States · 1 site
Registry update: 6 Nov 2026
NCT06303193
Recruiting
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Phase 1/2 · United States · 1 site
Registry update: 6 Nov 2026
NCT07572136
Recruiting
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1 · United States · 1 site
Registry update: 6 Nov 2026
NCT07619547
Recruiting
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07574541
Recruiting
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Phase 2 · United States · 1 site
Registry update: 6 Nov 2026
NCT07169630
Recruiting
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
Phase 1 · United States · 1 site
Registry update: 6 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.